![]() ![]() ![]() Pfizer and BioNTech are also facing patent infringement lawsuits from other companies. TransData, Inc., a leading developer and manufacturer of digital electricity meters and related energy measurement products for the electric utility industry for over 45 years, announced that the company has filed patent infringement lawsuits in the United States District Court for the Eastern District of Texas against General Electric (NYSE. The companies have previously told the court that their COVID vaccine Comirnaty does not work in the same way as CureVac's patented technology. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. ![]() Pfizer and BioNTech in response had filed a complaint with the U.S. The lawsuit filed by TransData alleges that these three companies have engaged in willfully infringing upon three of TransData’s patents through the U.S. Pfizer and BioNTech did not immediately respond to requests for comment. The transfer of the trial to the Eastern District of Virginia from the Federal District Court of Massachusetts is expected to accelerate progress of the case and allow for a likely 2024 trial date, CureVac said on Friday. In July 2022, CureVac had filed a patent lawsuit against BioNTech over the use of mRNA technology in the companies' COVID-19 vaccine. The company said it filed a counterclaim alleging that Pfizer and its German partner BioNTech infringed on nine of its patents, broader than its original claim of three patents. court had granted its request to transfer the trial. General Electric Company and GE Energy Management Services. May 19 (Reuters) - CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc (PFE.N) and BioNTech over the use of mRNA technology and that a U.S. alleged patent infringement suit concerning contactless payment systems. ![]()
0 Comments
Leave a Reply. |